Researchers validate the REDMOD AI framework, which detects early, otherwise invisible, tissue changes of pancreatic cancer on CT scans before clinical diagnosis.
Key Details
- 1REDMOD is an AI radiomics model for detecting subtle texture changes indicative of stage 0 pancreatic ductal adenocarcinoma on CT.
- 2The model identified preclinical disease an average of 475 days before clinical diagnosis.
- 3In head-to-head comparison, REDMOD's sensitivity was nearly double that of expert radiologists (73% vs. 39%).
- 4Performance remained high (68% vs. 23%) for cancers detected over two years before diagnosis.
- 5The model showed strong generalisability in external cohorts (correctly identifying >81% and 87.5% of cases in independent datasets).
- 6Researchers caution further prospective validation and testing in high-risk patients are needed before clinical adoption.
Why It Matters
Ultra-early detection of pancreatic cancer could dramatically improve survival rates by enabling treatment before symptoms arise. AI models like REDMOD may soon provide radiologists with powerful new tools to catch deadly cancers in their most treatable phases.
Source
EurekAlert
Related News
•EurekAlert
New Framework Compares AI Segmentation Without Ground Truth Annotations
Researchers introduce an open-source approach for evaluating AI anatomy segmentation models in medical imaging without requiring ground truth annotations.
•EurekAlert
HKU Develops AI-Enabled Optical Device for Rapid, Non-Invasive Cancer Risk Assessment
The University of Hong Kong has introduced a portable AI-enabled optical device for rapid, non-invasive cancer risk detection using saliva samples.
•EurekAlert
AI-Driven Handheld Endomicroscope Enhances Early Cancer Detection
Researchers develop PrecisionView, a handheld AI-powered endomicroscope for real-time, high-resolution cancer diagnostics.